Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Catalent, Inc. Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Market Rally At Highs, Led By Apple, Growth Stocks: Weekly Review ↗

September 03, 2021

The market rally hit fresh highs this week, with growth leading the way.

Via Investor's Business Daily

Topics Bonds Economy Stocks

10 Biggest Price Target Changes For Tuesday ↗

August 31, 2021

Morgan Stanley raised Lowe's Companies, Inc. (NYSE:L...

Via Benzinga

Catalent, inc (CTLT) Q4 2021 Earnings Call Transcript ↗

August 30, 2021

CTLT earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Mid-Afternoon Market Update: Affirm Shares Jump Following News Of Amazon Partnership; Adtran Shares Drop ↗

August 30, 2021

Toward the end of trading Monday, the Dow traded up 0.02% to 35,462.17 while the NASDAQ rose 1.02% to 15,283.07. The S&P also rose, gaining 0.59% to 4,535.90. The U.S. has the...

Via Benzinga

Topics Stocks

Catalent's Debt Overview ↗

August 25, 2021

Shares of Catalent (NYSE:CTLT) rose by 23.76% in the past three months. Before having a look at the importance of debt, let us look at how much debt Catalent has. Catalent...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

Mid-Day Market Update: Nasdaq Jumps Over 100 Points; Astra Space Shares Plunge ↗

August 30, 2021

Midway through trading Monday, the Dow traded up 0.10% to 35,490.10 while the NASDAQ rose 0.85% to 15,258.38. The S&P also rose, gaining 0.59% to 4,536.02. The U.S. has the...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Catalent To Acquire Bettera ↗

August 30, 2021

Following the market opening Monday, the Dow traded down 0.13% to 35,408.32 while the NASDAQ rose 0.61% to 15,221.76. The S&P also rose, gaining 0.32% to 4,523.75. The U.S....

Via Benzinga

Topics Stocks

Catalent Makes Strategic Move For Consumer Health Business With Bettera Deal ↗

August 30, 2021

Catalent Inc (NYSE: CTLT) has reported Q4 sales of $1.19 billion, +25% Y/Y as reported, or 22% in constant currency, edging out analysts' average expectation...

Via Benzinga

Catalent to Extend Leadership in Rapidly Growing Nutraceuticals Market with Proposed $1 Billion Acquisition of Bettera, a Leading Gummies Manufacturer

August 30, 2021

From Catalent, Inc.

Via Business Wire

Catalent, Inc. Reports Fourth Quarter Fiscal 2021 Results

August 30, 2021

From Catalent, Inc.

Via Business Wire

Highlander Partners Announces the Signing of a Definitive Agreement to Sell Bettera Brands to Catalent

August 30, 2021

From Highlander Partners

Via Business Wire

A Peek Into The Markets: US Stock Futures Edge Higher After S&P 500, Nasdaq Hit Record Highs ↗

August 30, 2021

Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the S&P and the Nasdaq hit record closing highs in the previous session following...

Via Benzinga

Topics Stocks

5 Stocks To Watch For August 30, 2021 ↗

August 30, 2021

Some of the stocks that may grab investor focus today are: Wall Street expects Zoom Video Communications Inc (NASDAQ: ZM) to report quarterly earnings at $1.16 per share on...

Via Benzinga

Earnings Scheduled For August 30, 2021 ↗

August 30, 2021

Companies Reporting Before The Bell Catalent Inc (NYSE: CTLT) is expected to report quarterly earnings at $1.03 per share on revenue of $1.14 billion. Cloudera, Inc. (NYSE: CLDR...

Via Benzinga

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗

August 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Topics Intellectual Property

A Look Into Catalent's Price Over Earnings ↗

August 25, 2021

In the current market session, Catalent Inc. (NYSE:CTLT) is trading at $126.21, after a 0.1% drop. However, over the past month, the stock went up by 8.33%, and in...

Via Benzinga

EMA Approves Additional Sites To Boost Output Capacity For mRNA-Based COVID-19 Vaccines ↗

August 25, 2021

European Medical Agency (EMA) has approved additional manufacturing sites for mRNA-based coronavirus vaccines developed by Pfizer Inc (NYSE: PFE) - ...

Via Benzinga

Unusual Options Activity Insight: Catalent ↗

August 16, 2021

On Monday, shares of Catalent (NYSE:CTLT) saw unusual options activity. After the option alert, the stock price moved up to $121.14. Sentiment: BEARISH Option Type: TRADE Trade...

Via Benzinga

Catalent, Inc. Announces Fourth Quarter Fiscal Year 2021 Earnings Conference Webcast

August 06, 2021

From Catalent, Inc.

Via Business Wire

Catalent Achieves 97% Renewable Electricity Sourcing and Commits to Science-Based Target Initiative to Reduce Carbon Footprint

August 03, 2021

From Catalent, Inc.

Via Business Wire

2 Stocks Insiders Are Buying ↗

July 29, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

Catalent Plans $100M Expansion Of Biologics Capabilities At Italian Vaccine Plant ↗

July 21, 2021

Catalent Inc (NYSE: CTLT) will begin the first phase of a planned $100 million expansion at its facility in Anagni, Italy, to add biologics drug substance manufacturing...

Via Benzinga

Moderna's COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested ↗

June 29, 2021

Moderna Inc (NASDAQ: MRNA) has announced new results from in vitro neutralization studies of sera from individuals vaccinated with its COVID-19 vaccine. The COVID-...

Via Benzinga

5 Top ETFs With Exposure To Biogen ↗

June 07, 2021

For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that...

Via Benzinga

Catalent, Inc. to Present at the Biopharma CEO Investor Forum

June 04, 2021

From Catalent, Inc.

Via Business Wire

AstraZeneca Seeks Switching COVID-19 Vaccine Production to Catalent Plant: NYT ↗

June 03, 2021

AstraZeneca Plc (NASDAQ: AZN) is in talks with the U.S. government to shift production of its COVID-19 vaccine from a troubled Emergent BioSolutions Inc’s (...

Via Benzinga

Catalent, Inc. to Present at the Jefferies Healthcare Conference and the William Blair Growth Stock Conference

May 28, 2021

From Catalent, Inc.

Via Business Wire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.